Analystreport

Stoke Therapeutics, Inc. (NASDAQ: STOK) had its price target raised by analysts at Cantor Fitzgerald from $20.00 to $25.00.

Stoke Therapeutics, Inc.  (STOK) 
Last stoke therapeutics, inc. earnings: 11/12 08:00 am Check Earnings Report